Patents by Inventor Lanping Xiao

Lanping Xiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucose-6-phosphate dehydrogenase mutant and use thereof in preparing detection reagent
    Patent number: 12517120
    Abstract: Disclosed is a glucose-6-phosphate dehydrogenase mutant and a use thereof in preparing a detection reagent. Compared with a wild-type glucose-6-phosphate dehydrogenase mutant, the glucose-6-phosphate dehydrogenase mutant contains a combination of the following mutations: 56C, 306C, and 454C. A detection kit prepared by using the glucose-6-phosphate dehydrogenase has strong specificity, high sensitivity, convenient operation, a short detection time, accurate quantification, and is suitable for high-throughput detection.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: January 6, 2026
    Assignee: Beijing Strong Biotechnologies, Inc.
    Inventors: Jun Gong, Lanping Xiao, Jinxiang Qi, Qifei Zhang, Guili Wang, Xi Liu
  • GLUCOSE-6-PHOSPHATE DEHYDROGENASE MUTANT AND USE THEREOF IN PREPARING DETECTION REAGENT
    Publication number: 20230243819
    Abstract: Disclosed is a glucose-6-phosphate dehydrogenase mutant and a use thereof in preparing a detection reagent. Compared with a wild-type glucose-6-phosphate dehydrogenase mutant, the glucose-6-phosphate dehydrogenase mutant contains a combination of the following mutations: 56C, 306C, and 454C. A detection kit prepared by using the glucose-6-phosphate dehydrogenase has strong specificity, high sensitivity, convenient operation, a short detection time, accurate quantification, and is suitable for high-throughput detection.
    Type: Application
    Filed: November 4, 2020
    Publication date: August 3, 2023
    Inventors: Jun Gong, Lanping Xiao, Jinxiang Qi, Qifei Zhang, Guili Wang, Xi Liu
  • QUANTITATIVE KIT FOR MYXOVIRUS RESISTANCE PROTEIN 1
    Publication number: 20230049153
    Abstract: The present application relates to a quantitative kit for myxovirus resistance protein 1. Specifically, a kit comprising latex particles coated with a myxovirus resistance protein 1 antibody is disclosed. Myxovirus resistance protein 1 in human serum and plasma samples and latex particles cross-linked with a myxovirus resistance protein 1 antibody are specifically binded to form a complex, which leads to an increase in absorbance. By detecting changes in immunoturbidity, a higher sensitivity and a wider detection range are reached.
    Type: Application
    Filed: November 4, 2020
    Publication date: February 16, 2023
    Inventors: Jun Gong, Jinxiang Qi, Lanping Xiao, Guili Wang, Xi LlU